FindTrial
Sign In

Second Line Agents in Myositis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN40085050
Enrollment
Unknown
Registered
2002-02-04
Start date
2003-03-10
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory myositis Musculoskeletal Diseases Myositis

Interventions

Patients will be randomised to receive methotrexate, cyclosporin A, both or matching placebos

Sponsors

Arthritis Research Campaign (ARC) (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with inflammatory myositis

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 7, 2026